1. |
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009[J]. CA Cancer J Clin, 2009, 59(4):225-249.
|
2. |
Jema1 A, Bray F, Center MM, et a1. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2):69-90.
|
3. |
Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993, 75(5):843-854.
|
4. |
Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase Ⅱ[J]. EMBO J, 2004, 23(20):4051-4060.
|
5. |
Borchert GM, Lanier W, Davidson BL. RNA polymerase Ⅲ transcribes human microRNAs[J]. Nat Struct Mol Biol, 2006, 13(12):1097-1101.
|
6. |
Lee Y, Han J, Yeom KH, et al. Drosha in primary microRNA processing[J]. Cold Spring Harb Symp Quant Biol, 2006, 71(8):51-57.
|
7. |
Várallyay É, Burgyán J, Havelda Z. Detection of microRNAs by northern blot analyses using LNA probes[J]. Methods, 2007, 43(2):140-145.
|
8. |
Castoldi M, Schmidt S, Benes V, et al. miChip:an array-based method for microRNA expression profiling using locked nucleic acid capture probes[J]. Nat Protoc, 2008, 3(2):321-329.
|
9. |
Yao Y, Guo G, Ni Z, et al. Cloning and characterization of microRNAs from wheat (Triticum aestivum L.)[J]. Genome Biol, 2007, 8(6):R96.
|
10. |
Raymond CK, Roberts BS, Garrett-Engele P, et al. Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs[J]. RNA, 2005, 11(11):1737-1744.
|
11. |
Ji R, Cheng Y, Yue J, et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation[J]. Circ Res, 2007, 100(11):1579-1588.
|
12. |
Zhu S, Si ML, Wu H, et al. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1(TPM1)[J]. J Biol Chem, 2007, 282(19):14328-14336.
|
13. |
Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21(miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer[J]. Oncogene, 2008, 27(15):2128-2136.
|
14. |
Chen Y, Liu W, Chao T, et al. MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G[J]. Cancer Lett, 2008, 272(2):197-205.
|
15. |
Gabriely G, Wurdinger T, Kesari S, et al. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators[J]. Mol Cell Biol, 2008, 28(17):5369-5380.
|
16. |
Fujita S, Ito T, Mizutani T, et al. miR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism[J]. J Mol Biol, 2008, 378(3):492-504.
|
17. |
Qin W, Zhao B, Shi Y, et al. BMPRⅡ is a direct target of miR-21[J]. Acta Biochim Biophys Sin (Shanghai), 2009, 41(7):618-623.
|
18. |
Lieberman D. Progress and challenges in colorectal cancer screening and surveitlance[J]. Gastroenterology, 2010, 138(6):2115-2126.
|
19. |
Graser A, Stieber P, Nagel D, et al. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population[J]. Gut, 2009, 58(2):241-248.
|
20. |
Bandrés E, Cubedo E, Agirre X, et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues[J]. Mol Cancer, 2006, 5(1):29-38.
|
21. |
Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets[J]. Proc Natl Acad Sci USA, 2006, 103(7):2257-2261.
|
22. |
Rossi L, Bonmassar E, Faraoni I. Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro[J]. Pharmacol Res, 2007, 56(3):248-253.
|
23. |
Yantiss RK, Goodarzi M, Zhou XK, et al. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma[J]. Am J Surg Pathol, 2009, 33(4):572-582.
|
24. |
Ng EK, Chong WW, Jin H, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer:a potential marker for colorectal cancer screening[J]. Gut, 2009, 58(10):1375-1381.
|
25. |
Kulda V, Pesta M, Topolcan O, et al. Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases[J]. Cancer Genet Cytogenet, 2010, 200(2):154-160.
|
26. |
Kanaan Z, Rai SN, Eichenberger MR, et al. Plasma miR-21:a potential diagnostic marker of colorectal cancer[J]. Ann Surg, 2012, 256(3):544-551.
|
27. |
Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma[J]. JAMA, 2008, 299(4):425-436.
|
28. |
Shibuya H, Iinuma H, Shimada R, et al. Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer[J]. Oncology, 2010, 79(3/4):313-320.
|
29. |
Wu CW, Ng SS, Dong YJ, et al. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps[J]. Gut, 2012, 61(5):739-745.
|
30. |
Link A, Balaguer F, Shen Y, et al. Fecal mieroRNAs as novel biomarkers for colon cancer screening[J]. Cancer Epidemiol Biomarkers Prey, 2010, 19(7):1766-1774.
|
31. |
Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma[J]. Br J Haematol, 2008, 141(5):672-675.
|
32. |
Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum:a novel class of biomarkers for diagnosis of cancer and other diseases[J]. Cell Res, 2008, 18(10):997-1006.
|
33. |
Slaby O, Svoboda M, Fabian P, et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer[J]. Oncology, 2007, 72(5/6):397-402.
|
34. |
Yamamichi N, Shimomura R, Inada K, et al. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development[J]. Clin Cancer Res, 2009, 15(12):4009-4016.
|
35. |
李先承, 李秀男, 宋希双. MicroRNA-21与实体肿瘤关系的研究进展[J]. 大连医科大学学报, 2012, 34(2):182-188.
|
36. |
马一杰, 赵卫杰, 陈贝贝, 等. miR-21与结直肠癌细胞5-氟尿嘧啶化疗敏感性关系[J]. 中国保健营养, 2013(2):180-181.
|
37. |
Liu K, Li G, Fan C, et al. Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer[J]. J Int Med Res, 2011, 39(6):2288-2295.
|